Tuomo Alanko
- Oncology top 5%
- Molecular Biology
- Genetics top 10%
- Cancer Research top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Petri BonoOlli SakselaLeena‐Maija SoveriHelena IsoniemiTuija PoussaPia ÖsterlundTaina Turpeenniemi‐HujanenR. Asola
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)CAR-T cell therapy research (8 papers)Prostate Cancer Treatment and Research (8 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- FinlandUnited StatesFrance
In The Last Decade
Tuomo Alanko
29 papers receiving 924 citations
Peers
Comparison fields: 5 of 72
- Oncology 717
- Molecular Biology 252
- Genetics 251
- Cancer Research 190
- Radiology, Nuclear Medicine and Imaging 165
Countries citing papers authored by Tuomo Alanko
This map shows the geographic impact of Tuomo Alanko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuomo Alanko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuomo Alanko more than expected).
Fields of papers citing papers by Tuomo Alanko
This network shows the impact of papers produced by Tuomo Alanko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuomo Alanko. The network helps show where Tuomo Alanko may publish in the future.
Co-authorship network of co-authors of Tuomo Alanko
This figure shows the co-authorship network connecting the top 25 collaborators of Tuomo Alanko. A scholar is included among the top collaborators of Tuomo Alanko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuomo Alanko. Tuomo Alanko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 21 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 11 | |
| 10 | 2 | |
| 11 | 11 | |
| 12 | 144 | |
| 13 | 107 | |
| 14 | 19 | |
| 15 | 9 | |
| 16 | 15 | |
| 17 | 45 | |
| 18 | 6 | |
| 19 | 8 | |
| 20 | 16 |
About Tuomo Alanko
Tuomo Alanko is a scholar working on Oncology, Hepatology and Biotechnology, having authored 32 papers that have together received 947 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (8 papers) and Prostate Cancer Treatment and Research (8 papers). The work is most often cited by research in Oncology (717 citations), Cancer Research (190 citations) and Genetics (251 citations). Tuomo Alanko has collaborated with scholars based in Finland, United States and France. Frequent co-authors include Petri Bono, Olli Saksela, Leena‐Maija Soveri, Helena Isoniemi, Tuija Poussa, Pia Österlund, Taina Turpeenniemi‐Hujanen, R. Asola, Heikki Joensuu and R. Kokko. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.